MeSH term
Frequency | Condition_Probility | Humans | 34 | 0.0 |
Animals | 11 | 0.0 |
Binding Sites | 3 | 0.0 |
Muscles/enzymology | 2 | 3.0 |
Rabbits | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Adult | 5 | 0.0 |
Aged | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Female | 7 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 3 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Blotting, Western | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Glycophorin/*genetics | 8 | 28.0 |
MNSs Blood-Group System/*genetics | 4 | 36.0 |
Variation (Genetics) | 4 | 0.0 |
Genes, Structural | 4 | 0.0 |
Phenotype | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Base Sequence | 9 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Blotting, Southern | 6 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
Exons | 4 | 0.0 |
Drug Therapy, Combination | 2 | 0.0 |
*Gene Expression | 2 | 0.0 |
Glycophorin/deficiency/*genetics | 3 | 100.0 |
Mutation | 2 | 0.0 |
Nucleic Acid Hybridization | 5 | 0.0 |
Sialoglycoproteins/*genetics | 6 | 9.0 |
DNA Probes | 5 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
*Evolution | 2 | 1.0 |
Reference Values | 2 | 0.0 |
